A 28-year-old woman at 12 weeks gestation presents to the emergency department with severe nausea, vomiting, and vaginal bleeding. Her fundal height is larger than expected for gestational age. Which assessment finding would be most characteristic of a hydatidiform mole?

Hydatidiform mole is characterized by markedly elevated beta-hCG levels due to excessive trophoblastic proliferation, making this the most diagnostic finding. Other options represent normal pregnancy findings or unrelated symptoms.

Core Nursing Explanation Key Concept Analysis: This question assesses the ability to identify the classic diagnostic sign of a Hydatidiform Mole (Molar Pregnancy). A molar pregnancy is a type of Gestational Trophoblastic Disease (GTD) where abnormal fertilization leads to the proliferation of trophoblastic tissue (which forms the placenta) into grapelike clusters, with no viable embryo. The core pathophysiological mechanism is the excessive, uncontrolled proliferation of trophoblastic cells. These cells produce human chorionic gonadotropin (hCG), leading to serum levels that are Key Point! disproportionately and significantly higher than those seen in a normal singleton pregnancy at the same gestational age.

Answer Rationale: The most characteristic finding is a Serum beta-hCG level significantly elevated above normal pregnancy values. This is a direct biochemical marker of the underlying pathology. The clinical presentation (severe nausea/vomiting, vaginal bleeding, and a fundal height larger than dates) are all suggestive signs, but the markedly elevated beta-hCG is the definitive laboratory hallmark that strongly points toward a molar pregnancy diagnosis, which would be confirmed by ultrasound showing a "snowstorm" appearance and no fetal parts.

Distractor Analysis:
Watch out for confusion! Option ①: The presence of fetal heart tones (FHT) is characteristic of a viable pregnancy. In a complete molar pregnancy, there is no fetus. Therefore, detecting FHT would rule out a classic complete mole and point toward other diagnoses (e.g., threatened abortion with a viable fetus, or a partial mole which may have some fetal tissue but is still abnormal).
Option ②: A normal blood pressure and urinalysis are not characteristic of a molar pregnancy. While preeclampsia (hypertension and proteinuria) is a risk associated with molar pregnancies, it typically occurs later (after 20 weeks). Its absence in this early presentation does not help diagnose the mole; it merely rules out one potential complication.
Option ④: Cervical dilation with intact membranes is a sign of Inevitable or incomplete abortion in a normal pregnancy. While vaginal bleeding is common in both miscarriage and molar pregnancy, the specific finding of cervical dilation is more directly indicative of spontaneous abortion rather than the trophoblastic proliferation seen in a mole.

Related Concepts: Molar pregnancies are classified as Complete (no fetal tissue, 46XX karyotype usually from paternal origin only) and Partial (some fetal tissue, triploid karyotype). They are a risk factor for persistent trophoblastic disease and choriocarcinoma, necessitating careful follow-up with serial beta-hCG monitoring for up to a year after treatment (uterine evacuation via dilation and curettage - D&C). Concept Summary

Concept	Key Points
Hydatidiform Mole (Molar Pregnancy)	Benign GTD. Abnormal trophoblast proliferation forms grapelike vesicles. No viable fetus in complete mole.
Pathognomonic Sign	Key Point! Serum beta-hCG levels markedly elevated for gestational age.
Classic Clinical Triad ("Classic Presentation")	1. Vaginal bleeding (often dark brown, "prune juice"). 2. Uterine size larger than dates (for gestational age). 3. Severe nausea/vomiting (hyperemesis gravidarum).
Diagnostic Confirmation	Transvaginal ultrasound shows "snowstorm" or "cluster of grapes" appearance with no fetal pole.
Major Complication & Nursing Priority	Risk of hemorrhage during/after evacuation. Risk of progression to malignant GTD (e.g., choriocarcinoma). Follow-up with serial beta-hCG is critical.

Side-by-Side Comparison!

Finding	Hydatidiform Mole	Normal Intrauterine Pregnancy	Spontaneous Abortion (Miscarriage)
Beta-hCG Trend	Extremely high, rises rapidly	Doubles approximately every 48 hrs in early pregnancy	Levels plateau or decline
Ultrasound Findings	"Snowstorm" pattern, no fetal heart activity	Gestational sac, yolk sac, fetal pole, cardiac activity	Irregular sac, no cardiac activity, may show products of conception
Uterine Size	Often larger than dates	Consistent with dates	May be smaller than dates
Associated Symptoms	Hyperemesis, early preeclampsia, hyperthyroidism (rare)	Normal pregnancy symptoms (nausea, breast tenderness)	Cramping, bleeding, passage of tissue

Anatomy, Physiology & Pharmacology Points Physiology: Trophoblastic cells are the precursors to the placenta. They secrete hCG, which maintains the corpus luteum to produce progesterone in early pregnancy. In a mole, the abnormal proliferation leads to massive overproduction of hCG.
Pharmacology: Methotrexate is sometimes used to treat persistent gestational trophoblastic neoplasia (GTN) after a molar pregnancy. It is a folic acid antagonist that targets rapidly dividing cells. Memory Tips Mnemonic for Molar Pregnancy Signs: "Very High hCG"
Vaginal bleeding (prune juice)
Hyperemesis
hCG levels sky-high
Clusters of grapes on ultrasound
Greater uterine size (larger than dates)

Remember: No FHT in a complete mole. If you hear heart tones, think "viable pregnancy" or a different problem. High-Frequency NCLEX Topics The NCLEX loves to test the classic triad of symptoms and the markedly elevated beta-hCG as the key diagnostic clue. You may also see questions on:
1. Priority nursing care post-evacuation (monitoring for hemorrhage, infection).
2. Patient education for follow-up: The critical importance of serial beta-hCG monitoring (weekly until normal x3, then monthly for 6-12 months) and pregnancy prevention (using reliable contraception) during that time to detect malignant transformation.
3. Recognizing signs of complications like metastatic disease (e.g., cough, hemoptysis suggesting lung metastases). Watch Out for Question Variations! * Instead of "most characteristic finding," the question could ask: "Which lab result would the nurse anticipate?" (Answer: Elevated beta-hCG). * Or: "The nurse is preparing a client with a suspected molar pregnancy for an ultrasound. What finding would confirm the diagnosis?" (Answer: "Snowstorm" appearance with no fetal parts). * Or a priority action: "Following evacuation of a hydatidiform mole, what is the nurse's priority teaching?" (Answer: Importance of follow-up beta-hCG testing to screen for choriocarcinoma).

Nursing Clinical Practice Guide Clinical Scenario: You are a nurse in the OB-GYN clinic. A patient, G1P0, at 10 weeks gestation by LMP (last menstrual period) presents with intermittent dark brown vaginal spotting and severe morning sickness requiring IV hydration last week. Her uterus feels firm and is palpable at the umbilicus (should be at symphysis pubis level). A stat beta-hCG returns at 450,000 mIU/mL (normal range for 10 weeks is roughly 25,000-288,000 mIU/mL, but this is at the extreme high end). Transvaginal ultrasound is ordered.

Nursing Intervention Strategy: 1. Assessment: Perform a thorough history and physical. Monitor vital signs for signs of hemorrhage or hyperthyroidism (tachycardia). Assess vaginal bleeding (amount, color, presence of tissue). Assess for signs of preeclampsia (BP, headache, visual changes, epigastric pain) even though it's early. 2. Support & Preparation: Provide emotional support. The patient was expecting a baby and is now facing a loss and a potential neoplastic condition. Explain the diagnostic process (ultrasound, likely D&C procedure). Prepare the patient for the possibility of no fetal heartbeat on ultrasound. 3. Post-Diagnosis Care: If a molar pregnancy is confirmed: * Pre-op for D&C: Ensure informed consent, NPO status, IV access. * Post-op: Monitor for complications - Key Point! Hemorrhage (check pad count, vital signs, fundal firmness) and infection (fever, foul-smelling discharge, uterine tenderness). * Patient Education: This is the most critical nursing role.

Patient Safety and Precautions: * Contraindications: The patient must avoid pregnancy for the entire follow-up period (usually 6-12 months) as a new pregnancy would produce hCG and make it impossible to monitor for persistent disease. Reliable contraception (e.g., oral contraceptives, IUD) is essential. * Medication Cautions: If methotrexate is used for persistent GTN, monitor for side effects (stomatitis, hepatotoxicity, bone marrow suppression). * Key Monitoring Points: Serial quantitative beta-hCG levels. Any plateau or rise in hCG after evacuation indicates persistent trophoblastic disease requiring further treatment. Nursing Procedure & Medication Flow Procedure: Assisting with Dilation & Curettage (D&C) for Molar Pregnancy 1. Pre-Procedure: Verify consent, confirm NPO, establish IV line, administer preoperative medications as ordered. 2. Intra-Procedure: Assist the provider. Prepare for potential oxytocin administration during or after the procedure to promote uterine contraction and minimize bleeding. 3. Post-Procedure: * Monitor in PACU: Vital signs q15min until stable, pain assessment, vaginal bleeding. * Calculate blood loss: Weigh pads/chux (1 gram = 1 mL blood). * Administer Rhogam if patient is Rh-negative. * Provide discharge instructions emphasizing follow-up appointments and beta-hCG draws. A Word from Your Senior Nurse "Nursing care for a molar pregnancy is a blend of acute clinical management and long-term supportive care. In the moment, your focus is on physical safety—preventing hemorrhage and infection. But your lasting impact comes from the education and emotional support you provide. Helping a patient understand why she must wait to try again for a baby, and the importance of those monthly blood draws, is what empowers her to navigate this challenging journey. On the NCLEX, they're testing not just if you know the high hCG level, but if you understand the implications of that finding for the patient's ongoing care. Always connect the lab value to the living, breathing person in front of you."